Skip to main content

Health: Terminal Illness

Volume 707: debated on Tuesday 10 February 2009

Question

Asked by

To ask Her Majesty's Government what discussions they will have with the National Institute for Health and Clinical Excellence about the need to fund treatment for more patients with terminal illnesses who can experience life extensions from certain treatments. [HL1194]

On 2 January 2009, the National Institute for Health and Clinical Excellence (NICE) issued supplementary advice to its appraisal committees, to provide more flexibility in the evaluation of higher-cost drugs which have been shown to extend the lives of terminally ill patients with less common conditions. This advice is available on NICE's website at www.nice.org.uk/aboutnice/howwework/devnicetech/endoflifetreatments.jsp. A copy has also been placed in the Library.

Primary care trusts have a legal duty to provide funding for treatments recommended in NICE technology appraisals, within three months of the publication of NICE guidance.

I have no plans to discuss this issue with NICE.